NCT03178630View on ClinicalTrials.gov

MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

February 28, 2030

Study Completion Date

February 28, 2031

Conditions
Autoimmune Liver DiseaseAutoimmune HepatitisPrimary Sclerosing Cholangitis
Trial Locations (1)

45229

RECRUITING

Cincinnati Children's Hospital and Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER